Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study (original ) (raw )Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine
Durk Wiersma
Journal of Psychopharmacology, 2012
View PDFchevron_right
The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study
Dick Veltman
Journal of Psychopharmacology, 2014
View PDFchevron_right
Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone
Suzannah Zimmet
Schizophrenia Research, 2003
View PDFchevron_right
Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: Preliminary results
Maciej Buchowski
Psychiatry Research: Neuroimaging, 2013
View PDFchevron_right
Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity
Nikolaos Kelekis
npj Schizophrenia
View PDFchevron_right
Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse
abi hasan
2009
View PDFchevron_right
Cue Reactivity in the Ventral Striatum Characterizes Heavy Cannabis Use, Whereas Reactivity in the Dorsal Striatum Mediates Dependent Use
Keith Kendrick
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2019
View PDFchevron_right
Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects
Nadia Solowij
Journal of Psychopharmacology, 2004
View PDFchevron_right
Clozapine decreases [3H] CP 55940 binding to the cannabinoid1 receptor in the rat nucleus accumbens
S. Sundram
Naunyn-Schmiedeberg's Archives of Pharmacology, 2005
View PDFchevron_right
Interaction of Cannabis Use Disorder and Striatal Connectivity in Antipsychotic Treatment Response
Christina Fales
Schizophrenia Bulletin Open, 2020
View PDFchevron_right
Clozapine treatment attenuated somatic and affective signs of nicotine and amphetamine withdrawal in subsets of rats exhibiting hyposensitivity to the initial effects of clozapine
Svetlana Semenova
Biological Psychiatry, 2003
View PDFchevron_right
An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
Jan Berle
Frontiers in Psychiatry, 2012
View PDFchevron_right
Neurobiology of Comorbid Substance Use Disorders in Mental Illness: A Closer Look at the Underlying Commonalities between Cannabis and Schizophrenia
Rishab Gupta
Current Addiction Reports, 2014
View PDFchevron_right
Marijuana craving in the brain
Ursula Myers
Proceedings of the National Academy of Sciences of the United States of America, 2009
View PDFchevron_right
Cannabinoid Receptor Antagonists Counteract Sensorimotor Gating Deficits in the Phencyclidine Model of Psychosis
Michele ZOLI
Neuropsychopharmacology, 2007
View PDFchevron_right
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency
Zoltan Makkos , Lilla Fejes
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
View PDFchevron_right
The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues
Michael Perdices
Australian and New Zealand Journal of Psychiatry, 2007
View PDFchevron_right
Lev-Ran 2012- Neurocognitive functions of heavy cannabis using schizophrenia patients
Yoram Braw
View PDFchevron_right
Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder
Mark Greenwald
Drug and Alcohol Dependence, 2016
View PDFchevron_right
Craving in Patients with Schizophrenia and Cannabis Use Disorders
Thomas Schnell
The Canadian Journal of Psychiatry, 2013
View PDFchevron_right
Inferior performance on selected neuropsychological tests in abstinent schizophrenia patients who have used cannabis
Krzysztof Krysta
Medical Science Monitor, 2012
View PDFchevron_right
Biological aspects of cannabis consumption in schizophrenia
dan madalina
Archives of Biological Sciences, 2014
View PDFchevron_right
Variable individual sensitivity to cannabis in patients with schizophrenia
David Gourion
International Journal of Neuropsychopharmacology, 2010
View PDFchevron_right
Neurocognitive functions of heavy cannabis using schizophrenia patients
Yoram Braw
European Psychiatry
View PDFchevron_right
Cannabis and cue-induced craving in cocaine-dependent individuals: A pilot study
Maykel Ghabrash
Addictive Behaviors, 2017
View PDFchevron_right
Cannabinoids and vanilloids in schizophrenia: Neurophysiological evidence and directions for basic research
Lezio S Bueno-Junior
Frontiers in Pharmacology, 2017
View PDFchevron_right
Cannabis, cannabinoids and schizophrenia: integration of the evidence
Vaughan Carr
Australian and New Zealand Journal of Psychiatry, 2008
View PDFchevron_right
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers
Stefan Borgwardt
2012
View PDFchevron_right
Induction of psychosis byδ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing
Stefan Borgwardt
View PDFchevron_right